Cargando…

Incretin hormones as immunomodulators of atherosclerosis

Atherosclerosis results from endothelial cell dysfunction and inflammatory processes affecting both macro- and microvasculature which are involved in vascular diabetic complications. Glucagon-like peptide-1 (GLP-1) is an incretin hormone responsible for amplification of insulin secretion when nutrie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso, Nuria, Julián, M. Teresa, Puig-Domingo, Manuel, Vives-Pi, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435665/ https://www.ncbi.nlm.nih.gov/pubmed/22973260 http://dx.doi.org/10.3389/fendo.2012.00112

Ejemplares similares

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
por: Ovlund, Tina, et al.
Publicado: (2021)

The Origin and Understanding of the Incretin Concept
por: Rehfeld, Jens F.
Publicado: (2018)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Detour Ahead: Incretin Hormone Signaling Alters Its Intracellular Path as β-Cell Failure Progresses During Diabetes
por: Hussain, Mehboob A., et al.
Publicado: (2021)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies
por: Pan, Qi, et al.
Publicado: (2022)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion
por: Jaghutriz, Benjamin Assad, et al.
Publicado: (2019)

Molecular mechanisms of incretin hormone secretion()
por: Ezcurra, Marina, et al.
Publicado: (2013)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
por: Milioti, Natalia, et al.
Publicado: (2008)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia
por: Batule, Sol, et al.
Publicado: (2022)

Effects of Incretin Pathway Elements on Bone Properties
por: Abdi, Arezoo M, et al.
Publicado: (2023)

Nutrient detection by incretin hormone secreting cells
por: Diakogiannaki, Eleftheria, et al.
Publicado: (2012)

Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension
por: Araos, Patricio, et al.
Publicado: (2022)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity
por: Stafeev, Iurii, et al.
Publicado: (2021)

A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity
por: Chhabria, Srishti, et al.
Publicado: (2022)

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(−/−) mice by blocking monocyte/macrophage activation
por: Kahles, Florian, et al.
Publicado: (2018)

Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome
por: Jagomäe, Toomas, et al.
Publicado: (2023)

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
por: Julián, María Teresa, et al.
Publicado: (2023)

Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
por: Perna-Barrull, David, et al.
Publicado: (2020)

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future
por: Lecis, Dalgisio, et al.
Publicado: (2023)

The role of the Wnt signaling pathway in incretin hormone production and function
por: Chiang, Yu-ting A., et al.
Publicado: (2012)

Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
por: Marathe, Chinmay S., et al.
Publicado: (2013)

GIP and GLP‐1, the two incretin hormones: Similarities and differences
por: Seino, Yutaka, et al.
Publicado: (2010)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
por: Michałowska, Joanna, et al.
Publicado: (2021)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
por: Galatou, Eleftheria, et al.
Publicado: (2022)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
por: Boer, Geke Aline, et al.
Publicado: (2020)

Luseogliflozin Additively Enhances the Glucose-Lowering Effect of an Incretin Modulator in a High-Carbohydrate Diet
por: Lee, Gendai
Publicado: (2022)

Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
por: Gil, Joan, et al.
Publicado: (2021)

Vitamin D: Nutrient, Hormone, and Immunomodulator
por: Sassi, Francesca, et al.
Publicado: (2018)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2horo31pasp12fr19tp5i1hql2